Current Neuropharmacology
Title:INTRODUCTORY CONSIDERATIONS Athanasios Koukopoulos: The Man, the Psychiatrist, the Original Thinker
Volume: 15 Issue: 3
Author(s): Hagop S. Akiskal
Affiliation:
Export Options
About this article
Cite this article as:
Akiskal S. Hagop, INTRODUCTORY CONSIDERATIONS Athanasios Koukopoulos: The Man, the Psychiatrist, the Original Thinker, Current Neuropharmacology 2017; 15 (3) . https://dx.doi.org/10.2174/1570159X14666161021100046
DOI https://dx.doi.org/10.2174/1570159X14666161021100046 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Galanin Receptor/Neuropeptide Y Receptor Interactions in the Central Nervous System
Current Protein & Peptide Science The Potential for Genetically Altered Microglia to Influence Glioma Treatment
CNS & Neurological Disorders - Drug Targets MMP-9, a Potential Target for Cerebral Ischemic Treatment
Current Neuropharmacology A Closer Look to Polyesters: Properties, Synthesis, Characterization, and Particle Drug Delivery Applications
Nanoscience & Nanotechnology-Asia Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Current Neuropharmacology Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
Current Medicinal Chemistry Structural Insights for Drugs Developed for Phospholipase D Enzymes
Current Drug Discovery Technologies Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application
Current Drug Metabolism Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases
Current Pharmaceutical Biotechnology Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer’s Disease
Current Alzheimer Research Formulation and Characterization of Mucoadhesive Microparticles of Cinnarizine Hydrochloride Using Supercritical Fluid Technique
Current Drug Delivery Synthesis of Imidazo[1,2-b]pyridazine Comprised Piperazine, Morpholine Derivatives as Potent Antimycobacterial Agents with In Vivo Locomotor Activity
Anti-Infective Agents Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders-Drug Targets Cingulate Volume Abnormalities in Emerging Psychosis
Current Pharmaceutical Design Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models
Current Pharmaceutical Design Transcranial Magnetic Stimulation to Understand the Pathophysiology and Treatment of Substance Use Disorders
Current Drug Abuse Reviews A New Battlefield Towards Global Health in 21<sup>st</sup> Century: Clinical Research Networks
Applied Clinical Research, Clinical Trials and Regulatory Affairs Bee Pollen: Chemical Composition and Potential Beneficial Effects on Health
Current Nutrition & Food Science Prevalence of Comorbid Anxiety Disorders in Schizophrenia Spectrum Disorders: A Literature Review
Current Psychiatry Reviews Editorial
Recent Patents on CNS Drug Discovery (Discontinued)